Last reviewed · How we verify
NCT05873023
Chewing Gum and Cognitive Function
NA trial testing Chewing gum in Cognitive Dysfunction in 94 participants. Status unknown.
15 December 2023
Quick facts
| Lead sponsor | Inha University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 94 |
| Start date | 17 October 2022 |
| Primary completion | 15 December 2023 |
| Estimated completion | 29 December 2023 |
| Sites | 4 locations across South Korea |
Drugs / interventions tested
- Chewing gum — full drug profile →
Conditions studied
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
Sponsor
Inha University Hospital
Who can join
Adults 60 to 79, any sex, with Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to investigate whether the improvement or maintenance of cognitive function is superior to the control group when gum chewing is performed in elderly people with subjective cognitive decline or mild cognitive impairment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05873023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Chewing gum
Trials testing the same drug.
- NCT06801860 — Chewing Gum for Smoking Cessation · NA · completed
- NCT07125742 — Effects of Chewing Gum, Fennel, and Ginger Tea on Intestinal Motility and Comfort After Cesarean · NA · completed
- NCT07084532 — Effects of Chewing Gum for Dry Mouth in Diabetes · NA · completed
- NCT05300750 — The Effect of Post Cesarean Section Protocol of Care on Early and Follow up Outcomes · NA · completed
- NCT03945461 — Return of Bowel Function After One or Two Level Anterior Lumbar Interbody Fusion With Chewing Gum · NA · completed
Other recruiting trials for Cognitive Dysfunction
Currently open trials in the same condition.
- NCT07526740 — Brain Stimulation and Cognitive Training for MCI · NA · recruiting
- NCT07517237 — taVNS + CCT for Neurocognitive Rehab · NA · recruiting
- NCT07171450 — Cognitive Remediation · NA · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
Other Inha University Hospital trials
Trials by the same sponsor.
- NCT07306520 — Effects of the Health Promotion Program on Health Literacy, Physical and Mental Health Status, and Quality of Life · NA · active not recruiting
- NCT05659420 — High Intensity Interval Training in Chronic Heart Failure · NA · unknown
- NCT06573268 — Da-vinci sp Versus xi Thyroid Surgery · completed
- NCT06963372 — Assessment of Health Effects of Air Purifier Interventions on Chronic Kidney Disease Patients · NA · completed
- NCT05301868 — Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive Impairment · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05873023 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inha University Hospital
- Last refreshed: 24 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05873023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing